Nothing comparable since the round — shown at its Series D, Jul 2024 ($1.0B post-money).
- ·37 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Element Biosciences funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Later Stage VC (Series D) | $277.0M | ▮ | ▮ |
| Jun 2021 | Later Stage VC (Series C) | $276.0M | ▮ | ▮ |
Membership and data by Private Market View
Element Biosciences valuation
Element Biosciences is valued at approximately $1 billion as of Oct 2026. The figure is set by institutional fund marks. The reference point is its Series D in Jul 2024, at a $1 billion post-money valuation.
Recent activity
In the last 90 days, Element Biosciences's record added 2 institutional fund marks (latest period Jul 2026).
How much has Element Biosciences raised?
Element Biosciences has raised $683 million across 2 recorded rounds since 2021. The largest was a $277 million Series D in Jul 2024.
Institutional holders and vehicles
3 SEC-registered funds reported 37 fair-value marks on Element Biosciences between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Comparable companies
Comparable other healthcare technology systems names by valuation on PrivateMarketView: Carbon Health ($1.3 billion), Zocdoc ($446 million) and Paradigm Health (Healthcare Technology Systems) ($443 million).
How Element Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Element Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Element Biosciences
- What is Element Biosciences worth?
- Element Biosciences is valued at $1.0B as of Oct 2026. Nothing comparable since the round — shown at its Series D, Jul 2024 ($1.0B post-money).
- How much has Element Biosciences raised?
- Element Biosciences has raised $683.3M in total funding across 2 recorded rounds.
- When did Element Biosciences last raise?
- Element Biosciences last raised in Jul 2024 (Later Stage VC (Series D)), raising $277.0M.